Followers | 1007 |
Posts | 30920 |
Boards Moderated | 0 |
Alias Born | 01/19/2010 |
Friday, April 23, 2021 7:35:49 AM
those screaming foul play are those that want your shares, i could care less if this collaboration is still in place, what matters is what is now in place with mrna & $onph...plus i think there are way more pieces of the puzzle we still have not put together
we are are ground zero here & i will do all in my power to take advantage of the few extra shares added to the o/s to give us this opportunity @ just ridiculous bottom prices...under 100 million market cap, not gonna fly here much longer imo
https://www.contractpharma.com/contents/view_breaking-news/2016-06-30/lilly-regen-biopharma-in-drug-discovery-pact/
Lilly, Regen BioPharma in Drug Discovery Pact
Regen will examine 21,000 Lilly compounds in its NR2F6 high-throughput screening program
Related CONTENT
PAREXEL Appoints SVP, CFO
Boehringer, Inovalon Enter Cloud Platform Pact
Lilly to Acquire CoLucid Pharma
12 Lilly
Intellectual Property for the Pharmaceutical Industry
06.30.16
Regen BioPharma has entered into a definitive agreement with Eli Lilly and Co. to receive compounds from Lilly for drug discovery purposes and allows Regen to share structural information on compounds of mutual interest.
Regen will examine 21,000 Lilly compounds in its NR2F6 high-throughput screening program to identify activators and inhibitors of this protein. NR2F6 is a molecular switch known as an "orphan nuclear receptor," which controls genes associated with the immune response as well as genes associated with the ability of cancer stem cells to propagate.
Lilly has an option to negotiate a compound purchase agreement, a license agreement, or a research collaboration agreement for further research and development of material of mutual interest.
"Lilly's Open Innovation Drug Discovery Program is visionary," said Harry Lander, Ph.D., MBA, president and chief scientific officer of Regen BioPharma, Inc. "They understand the value of partnering in a confidential manner with smaller entities that may have intellectual property that aligns with their product goals.”
DISCLAIMER: All my posts are MY OPINION and are not to be used as investment or trading advice. My posts are for entertainment purposes only. If you wish to Invest or trade, seek help from a Licensed broker.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM